Sinus delivery of sustained release therapeutics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7951130
APP PUB NO 20110066135A1
SERIAL NO

12883059

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INTERSECT ENT, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brenneman, Rodney A San Juan Capistrano, US 63 2938
Eaton, Donald J Los Altos, US 48 2780
Moran, Mary L Woodside, US 13 658

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation